Motivated by these findings and the therapeutic potential of CYP2W1 in cancer, this study aims to comprehensively investigate CYP2W1 expression across major STS subtypes affecting children and adolescents, evaluating its clinical relevance and prognostic value. Here, CYP2W1 is linked to telomere syndrome.